Category:
Other Preparations
Standard:
N;
Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.
Strength: 50mg/vial.
It is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.
MA issued from Spain, Netherlands CBG and UK MHRA.
Oxaliplatin for Injection is a sterile, lyophilized platinum-based antineoplastic agent manufactured via controlled crystallization and aseptic filtration. The core material consists of oxaliplatin complexed with diaminocyclohexane, formulated to ensure high chemical stability and purity for parenteral administration.